FDA Conditionally Approves Phenobarbital Tablets to Control Seizures in Dogs with Idiopathic Epilepsy

Today, the U.S. Food and Drug Administration conditionally approved Fidoquel-CA1 (phenobarbital tablets) for the control of seizures associated with idiopathic epilepsy in dogs. Idiopathic epilepsy is a type of seizure disorder without a known cause and is a serious or life-threatening condition that affects approximately 5% of dogs.